Low dose stereotactic irradiation and dexamethasone in primary cerebral light chain deposition disease (LCDD)
Leuk Lymphoma
.
2021 Sep;62(9):2267-2271.
doi: 10.1080/10428194.2021.1907380.
Epub 2021 Mar 31.
Authors
Daniel Authier
1
,
Ute Hegenbart
2
,
Fabian Pohl
3
,
Andreas Rosenwald
4
,
Stefan Kircher
4
,
Karin Menhart
5
,
Markus Perl
1
,
Jindrich Cerny
1
,
Stephanie Mayer
1
,
Wolfgang Herr
1
,
Matthias Grube
1
Affiliations
1
Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany.
2
Amyloidosis Center, University Hospital Heidelberg, Heidelberg, Germany.
3
Department of Radiotherapy, University Hospital Regensburg, Regensburg, Germany.
4
Institute of Pathology, University Würzburg, Würzburg, Germany.
5
Department of Nuclear Medicine, University Hospital Regensburg, Regensburg, Germany.
PMID:
33787427
DOI:
10.1080/10428194.2021.1907380
No abstract available
Publication types
Letter
MeSH terms
Dexamethasone
Humans
Immunoglobulin Light Chains
Multiple Myeloma*
Paraproteinemias*
Substances
Immunoglobulin Light Chains
Dexamethasone